208
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Rotavirus Vaccine Coverage and Associated Factors Among a Rural Population: Findings from a Primary Health-Care Project in Two Northwest Ethiopia Districts

, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 429-435 | Published online: 08 Oct 2020

References

  • Giaquinto C, Van Damme P, Group RS. Age distribution of paediatric rotavirus gastroenteritis cases in Europe: the REVEAL† study. Scand J Infect Dis. 2010;42(2):142–147. doi:10.3109/0036554090338049519916900
  • Grimwood K, Lambert SB, Milne RJ. Rotavirus infections and vaccines. Pediatric Drugs. 2010;12(4):235–256. doi:10.2165/11537200-000000000-0000020593908
  • Ansari SA, Springthorpe VS, Sattar SA. Survival and vehicular spread of human rotaviruses: possible relation to seasonality of outbreaks. Rev Infect Dis. 1991;13(3):448–461. doi:10.1093/clinids/13.3.4481866549
  • Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology. 2009;136(6):1939–1951. doi:10.1053/j.gastro.2009.02.07619457420
  • Clark A, Black R, Tate J, et al. Estimating global, regional and national rotavirus deaths in children aged< 5 years: current approaches, new analyses and proposed improvements. PLoS One. 2017;12(9):e0183392.28892480
  • Seheri LM, Page NA, Mawela MPB, et al. Rotavirus vaccination within the South African expanded programme on immunisation. Vaccine. 2012;30:C14–C20. doi:10.1016/j.vaccine.2012.04.01822939015
  • Troeger C, Blacker BF, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1211–1228. doi:10.1016/S1473-3099(18)30362-130243583
  • Yamashiro R, Sakudo A, Nagatsu M. Efficient recovery and enrichment of infectious rotavirus using separation with antibody-integrated graphite-encapsulated magnetic nanobeads produced by argon/ammonia gas plasma technology. Int J Nanomedicine. 2019;14:1865. doi:10.2147/IJN.S19178430880985
  • Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. doi:10.1056/NEJMoa05243416394298
  • Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. doi:10.1056/NEJMoa05266416394299
  • Organization WH. Rotavirus vaccines: WHO position paper—January 2013. Weekly Epidemiol Rec/Relevé épidémiologique hebdomadaire. 2013;88(05):49–64.
  • Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. The Lancet. 2010;376(9741):606–614. doi:10.1016/S0140-6736(10)60889-6
  • Troeger C, Khalil IA, Rao PC, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):958–965. doi:10.1001/jamapediatrics.2018.196030105384
  • Aliabadi N, Antoni S, Mwenda JM, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the Global Rotavirus Surveillance Network. Lancet Global Health. 2019;7(7):e893–e903. doi:10.1016/S2214-109X(19)30207-431200889
  • Soares‐Weiser K, Bergman H, Henschke N, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2019;10.
  • Doherty T, Rohde S, Besada D, et al. Reduction in child mortality in Ethiopia: analysis of data from demographic and health surveys. J Glob Health. 2016;6:2. doi:10.7189/jogh.06.020401
  • Wandera EA, Mohammad S, Ouko JO, et al. Variation in rotavirus vaccine coverage by sub-counties in Kenya. Trop Med Health. 2017;45(1):9. doi:10.1186/s41182-017-0051-z28450794
  • Wilson SE, Chung H, Schwartz KL, et al. Rotavirus vaccine coverage and factors associated with uptake using linked data: ontario, Canada. PLoS One. 2018;13(2):e0192809. doi:10.1371/journal.pone.019280929444167
  • Lucy W, Kanja AMP, Kirika L. Behavioral factors associated with the completion of rotavirus vaccine series in children attending pediatric asualty in a Public Hospital, Nairobi County, Kenya. Arch Commun Fam Med. 2018;1(1):24–32.
  • Aliabadi N, Wikswo ME, Tate JE, et al. Factors associated with rotavirus vaccine coverage. Pediatrics. 2019;143:2. doi:10.1542/peds.2018-1824
  • Kiwanuka S, Ekirapa E, Peterson S, et al. Access to and utilisation of health services for the poor in Uganda: a systematic review of available evidence. Trans R Soc Trop Med Hyg. 2008;102(11):1067–1074. doi:10.1016/j.trstmh.2008.04.02318565559
  • Kiros G-E, White MJ. Migration, community context, and child immunization in Ethiopia. Soc Sci Med. 2004;59(12):2603–2616. doi:10.1016/j.socscimed.2004.04.00915474213
  • Okwaraji YB, Mulholland K, Schellenberg J, et al. The association between travel time to health facilities and childhood vaccine coverage in rural Ethiopia. A community based cross sectional study. BMC Public Health. 2012;12(1):476. doi:10.1186/1471-2458-12-47622726457
  • Jones G, Steketee RW, Black RE, et al. How many child deaths can we prevent this year? The Lancet. 2003;362(9377):65–71. doi:10.1016/S0140-6736(03)13811-1
  • Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–141. doi:10.1016/S1473-3099(11)70253-522030330
  • Tate JE, Burton AH, Boschi-Pinto C, et al. World Health Organization Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children< 5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105.27059362
  • Organization WH. Global Rotavirus Information and Surveillance Bulletin. Geneva: WHO; 2013.
  • Health FMo. Ethiopia National Expanded Programme on Immunization: Addis Ababa: BMJ Publishing Group FMOE; 2015.
  • Olusanya BO. Pattern and determinants of BCG immunisation delays in a sub-Saharan African community. Health Res Policy Syst. 2010;8(1):1. doi:10.1186/1478-4505-8-120157426
  • Federal Ministry of Health E. Ethiopian National Expanded Program on Immunization Comprehensive Multi-Year Plan 2016–2020. Addis Ababa: FMOH; 2015 Available from:: https://extranet.who.int/countryplanningcycles/sites/default/files/country_docs/Ethiopia/ethiop_cmyp_latest_revised_may_12_2015.pdf. Accessed 929, 2020.
  • Girmay A, Dadi AF. Full immunization coverage and associated factors among children aged 12-23 months in a hard-to-reach areas of Ethiopia. Int J Pediatr. 2019;2019.
  • Mekonnen AG, Bayleyegn AD, Ayele ET. Immunization coverage of 12–23 months old children and its associated factors in Minjar-Shenkora district, Ethiopia: a community-based study. BMC Pediatr. 2019;19(1):1–8. doi:10.1186/s12887-019-1575-730606158
  • Gualu T, Dilie A. Vaccination coverage and associated factors among children aged 12–23 months in debre markos town, Amhara regional state, Ethiopia. Advan Public Health. 2017;2017.
  • Agency CS, ICF. Ethiopia Demographic and Health Survey 2016: Key Indicators Report. Addis Ababa, Ethiopia, and Rockville, Maryland, USA: CSA and ICF; 2016.
  • Adedokun ST, Uthman OA, Adekanmbi VT, et al. Incomplete childhood immunization in Nigeria: a multilevel analysis of individual and contextual factors. BMC Public Health. 2017;17(1):236. doi:10.1186/s12889-017-4137-728270125
  • Organization WH. WHO Recommendations on Postnatal Care of the Mother and Newborn: World Health Organization; 2014.